A new approach to women's pelvic health has attracted early capital, with femtherapeutics announcing $50K in Seed funding. The startup is tackling Pelvic Organ Prolapse, a condition impacting up to 50% of women and a $2B market in North America, with an inflatable pessary designed for personalized comfort.
This device, unlike existing options, will be available over the counter, aiming to make care more accessible and affordable. femtherapeutics is also building a digital platform to provide educational content, self-guided tools, and support from licensed providers, creating a comprehensive at-home experience.
